Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Carsgen Therapeutics, Ltd.)"
Count: 22
Selected: 0
NCT IDTitle
NCT04581473Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
NCT04404595Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
NCT04400383Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors
NCT03994913Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma
NCT03975907Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
NCT03915184Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
NCT03884751Chimeric Antigen Receptor T Cells Targeting Glypican-3
NCT02876978Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
NCT05838131Study of CT071 Injection in RRMM or PPCL
NCT05822037CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT05393986Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors
NCT05066022A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT04973098Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
NCT04963959PBMC Collection for Production of UCAR T Cells
NCT04756648Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma
NCT039802884th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
NCT03716856Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
NCT03380039Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
NCT03302403Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
NCT03159819Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma
NCT03146234CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma
NCT02933775CD19-redirected Autologous Cells (CAR-CD19 T Cells)